Sign in to view content

Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs

Ravi Parikh, MD MPH

Video
Published 2023

Related

Retina PractiCare 2.0 – Benchmarking your Practice
Annual Meeting Talks
2020
Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies
David M. Brown, MD
Annual Meeting Talks
2021
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019

Category: Socioeconomics

See more